WCN26-5831 AKI DURING TREATMENT OF MALIGNANCY— NEW CULPRITS

Read full text Summarise with VIRAT
Authors: Brittany McManaman, Preethi Subramanian, McKenna Johnson, Anatoly Urisman, Anil Agarwal
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Metastatic melanoma treatment includes immune-checkpoint inhibitors (ICIs) or targeted therapy.1 This case investigates the etiology of acute interstitial nephritis (AIN) in a patient transitioned from ICIs to BRAF-MEK inhibitors (BRAFi/MEKi).

Fields of Study & Subjects

Acute Kidney Injury Research Cancer Immunotherapy and Biomarkers Renal Diseases and Glomerulopathies

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104162–104162
Publication date
25 March 2026
Language
EN